Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Vogl

Showing results (231-240 of 342) with videos related to

Pageof 35
Sort By:
British Journal of Haematology|March 4, 2020
Selinexor-based regimens for the treatment of myeloma refractory to chimeric antigen receptor T cell therapyAjai Chari, Dan T Vogl, Sundar Jagannath, et al.
Rheumatology (Oxford, England)|March 19, 2008
T lymphocytes in patients with primary vasculitis: expansion of CD8+ T cells with the propensity to activate polymorphonuclear neutrophilsC Iking-Konert, T Vogl, B Prior, et al.
Leukemia & Lymphoma|May 10, 2007
Posttransplant lymphoproliferative disorder in adult liver transplant recipients: a report of seventeen casesHimisha Patel, Dan T Vogl, Nicole Aqui, et al.
Blood Advances|August 28, 2019
Serial treatment of relapsed/refractory multiple myeloma with different BCMA-targeting therapiesAdam D Cohen, Alfred L Garfall, Ahmet Dogan, et al.
Biorxiv : the Preprint Server for Biology|November 28, 2024
Neutrophil extracellular traps promote tumor chemoresistance to anthracyclinesCindy Lin, Sarah E Herlihy, Marina Li, et al.
The British Journal of Dermatology|January 17, 2013
Myeloid marker S100A8/A9 and lymphocyte marker, soluble interleukin 2 receptor: biomarkers of hidradenitis suppurativa disease activity?C W Wieland, T Vogl, A Ordelman, et al.
Annals of the Rheumatic Diseases|February 21, 2003
Myeloid related protein 8 and 14 secretion reflects phagocyte activation and correlates with disease activity in juvenile idiopathic arthritis treated with autologous stem cell transplantationN M Wulffraat, P J Haas, M Frosch, et al.
Transplantation Proceedings|December 1, 1996
Posttransplant malignancy and newer immunosuppressive protocols after liver transplantationS Jonas, W O Bechstein, N Rayes, et al.
The Lancet. Haematology|December 22, 2015
Financial toxicity in insured patients with multiple myeloma: a cross-sectional pilot studyScott F Huntington, Brendan M Weiss, Dan T Vogl, et al.
Annals of Surgery|April 4, 1998
Preoperative hyperthermia combined with radiochemotherapy in locally advanced rectal cancer: a phase II clinical trialB Rau, P Wust, P Hohenberger, et al.
Pageof 35

Showing results (231-240 of 342) with videos related to

Sort By:
Pageof 35
British Journal of Haematology|March 4, 2020
Selinexor-based regimens for the treatment of myeloma refractory to chimeric antigen receptor T cell therapyAjai Chari, Dan T Vogl, Sundar Jagannath, et al.
Rheumatology (Oxford, England)|March 19, 2008
T lymphocytes in patients with primary vasculitis: expansion of CD8+ T cells with the propensity to activate polymorphonuclear neutrophilsC Iking-Konert, T Vogl, B Prior, et al.
Leukemia & Lymphoma|May 10, 2007
Posttransplant lymphoproliferative disorder in adult liver transplant recipients: a report of seventeen casesHimisha Patel, Dan T Vogl, Nicole Aqui, et al.
Blood Advances|August 28, 2019
Serial treatment of relapsed/refractory multiple myeloma with different BCMA-targeting therapiesAdam D Cohen, Alfred L Garfall, Ahmet Dogan, et al.
Biorxiv : the Preprint Server for Biology|November 28, 2024
Neutrophil extracellular traps promote tumor chemoresistance to anthracyclinesCindy Lin, Sarah E Herlihy, Marina Li, et al.
The British Journal of Dermatology|January 17, 2013
Myeloid marker S100A8/A9 and lymphocyte marker, soluble interleukin 2 receptor: biomarkers of hidradenitis suppurativa disease activity?C W Wieland, T Vogl, A Ordelman, et al.
Annals of the Rheumatic Diseases|February 21, 2003
Myeloid related protein 8 and 14 secretion reflects phagocyte activation and correlates with disease activity in juvenile idiopathic arthritis treated with autologous stem cell transplantationN M Wulffraat, P J Haas, M Frosch, et al.
Transplantation Proceedings|December 1, 1996
Posttransplant malignancy and newer immunosuppressive protocols after liver transplantationS Jonas, W O Bechstein, N Rayes, et al.
The Lancet. Haematology|December 22, 2015
Financial toxicity in insured patients with multiple myeloma: a cross-sectional pilot studyScott F Huntington, Brendan M Weiss, Dan T Vogl, et al.
Annals of Surgery|April 4, 1998
Preoperative hyperthermia combined with radiochemotherapy in locally advanced rectal cancer: a phase II clinical trialB Rau, P Wust, P Hohenberger, et al.
Pageof 35